Pfizer slashes profit guidance as Covid vaccine sales disappoint
Shares sink to 10-year lowCost-cutting plan increased to $4 billion2024 earnings expected to be 30% below consensusA tough year for US pharmaceutical firm Pfizer (PFE:NYSE) just got even worse on Wednesday after the Covid winner reset expectations again.This disappointed investors and sent the shares 7% lower overnight to a new 10-year low.The news also dragged down the share price of Pfizer?s Ger